30.2% Below Target

The consensus Wall Street price target for CME is $320.67, representing 30.2% upside from the current price of $246.38. With 36 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.

CME has a consensus rating of "Hold" based on 36 Wall Street analysts. The rating breakdown is mixed, with 17 Hold ratings making up the largest segment. The consensus 12-month price target of $320.67 implies 30.2% upside from current levels.

CME trades at a forward P/E of 20.093x, representing a moderate valuation. With analysts targeting $320.67 (30.2% implied move), the stock appears reasonably valued with upside.

The most bullish Wall Street analyst has a price target of $353 for CME, while the most conservative target is $302. The consensus of $320.67 represents the median expectation. Our quantitative valuation model projects a bull case target of $437 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.

CME is heavily covered by Wall Street, with 36 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 14 have Buy ratings, 17 recommend Hold, and 5 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.

The 12-month CME stock forecast based on 36 Wall Street analysts shows a consensus price target of $320.67, with estimates ranging from $302 (bear case) to $353 (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $332, with bear/bull scenarios of $209/$437.

Our quantitative valuation model calculates CME's fair value at $332 (base case), with a bear case of $209 and bull case of $437. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 53/100.

CME trades at a forward P/E ratio of 20.1x based on next-twelve-months earnings estimates compared to a trailing P/E of 22.1x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.

Wall Street analysts are very optimistic on CME, with a "Hold" consensus rating and $320.67 price target (30.2% upside). 14 of 36 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.

CME analyst price targets range from $302 to $353, a 16% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $320.67 consensus represents the middle ground. Our model's $209-$437 range provides an independent fundamental perspective.